cGxP.wire https://validator.w3.org/feed/docs/rss2.html Actinium Forms Scientific Board to Guide Cancer Pipeline Aisa Pharma Reports Positive Phase II Data for AISA-021 Caris Reveals ESR1 Mutation Insights in Breast Cancer AbelZeta Reports CAR-T Data in Advanced Liver Cancer Lilly’s Foundayo Shows Positive Phase III Sleep Apnea Data ACP and OpenEvidence Partner to Advance Clinical AI Amgen Highlights Earlier Repatha Use at AHA 2026 OrthoTrophix Reports TPX-100 Data in Knee Osteoarthritis SetPoint Medical Reports 24-Month RA Treatment Data Ribo Files EU Phase I Trial for Dual-Targeting SR122 GlycoNex Submits Denosumab Biosimilar SPD8 in Japan InnoCare Advances Mesutoclax in Phase III AML Trial Regeneron’s CIDEB siRNA Cuts Liver Fat in Early Trial Vir Biotechnology Phase 3 Trial Meets Hepatitis Delta Goal BMS Reports 56-Week CAMZYOS Data in Pediatric oHCM Lilac Biosciences Appoints Adriana Coll De Peña as CEO AusperBio Reports 15-Month Hepatitis B Cure With AHB-137 Brii Bio Reports Phase 2 Progress in Hepatitis B Cure ImmunoGenesis Highlights IMGS-203 in Two Cancer Studies Skyhawk Doses First U.S. Patients in Huntington’s Trial Elysium Expands Peptide Access and Launches Research Programs Servier Expands Glioma Portfolio With New Cancer Data Bausch Health’s Salix Highlights Severe Alcohol-Associated Hepatitis Burden Antengene Unveils AnTenGager-D2 Preclinical Cancer Data Innovent Reports Phase 3 Tafolecimab Success in Lipids Novo Reports Wegovy Liver Marker Gains in Adults With MASH Allergan Reports Facial Satisfaction Gains Among GLP-1 Users J&J Reports 73% PSA Response in Advanced Prostate Cancer NYU Langone: Heart Procedures Show No Long-Term Survival Benefit Inimmune Reports Phase 1 INI-4001 Results for Solid Tumors Thermo Fisher Launches AmpSure Universal qPCR Master Mixes Biohaven Advances Pivotal Phase 3 Trial for Graves’ Disease Nuvo REACTIVE Trial Shows Gains in At-Home Fetal Monitoring Amgen Reports 20% Lower Heart Attack Risk With Repatha Zydus Reports Positive Phase 2b Saroglitazar MASH Data Novo Nordisk Reports Real-World Wegovy Benefits in MASH Onkos Wins FDA Clearance to Expand NanoCept Coating Theraclion Wins FDA Authorization for SONOVEIN HIFU Alfasigma Wins EU Approval for Filgotinib in axSpA HUTCHMED Wins FDA Orphan Status for Sovleplenib Acepodia Advances ACE723 Into Phase 1 Trial for Liver Cancer PulseAI Wins FDA Clearance for AI Wearable ECG Analysis MetaVia Reports 68% Liver Fat Reduction With DA-1726 Halozyme’s ENHANZE Powers FDA-Approved Cancer Therapy Johnson & Johnson Wins FDA Nod for RYBREVANT FASPRO ANI Pharmaceuticals’ $560M Offer for Egetis Therapeutics Bid Fairview Selects Layer Health for AI Clinical Registry Automation Rigel to Present Phase 1b R289 Data at ASH 2026 Telix Joins Thera4Care to Advance FAP-Targeted Cancer Therapy Citius Reports LYMPHIR Quality-of-Life Benefits in CTCL